TY - JOUR
T1 - Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.
AU - Sansone, Va
AU - Albamonte, E
AU - Salmin, F
AU - Casiraghi, J
AU - Pirola, A
AU - Bettinelli, M
AU - Rao, F
AU - Mancini, Lorena
AU - Tovaglieri, N
AU - Fedeli, F
AU - Stoia, P
AU - Heinen, M
AU - Cozzi, V
AU - Carraro, E
AU - Lunetta, C
AU - Di Bari, A
AU - Mercuri, Eugenio Maria
PY - 2018
Y1 - 2018
N2 - Nusinsersen is now available in Italy for all SMA types. We describe the experience with intrathecal treatment with nusinersen in 50 patients with SMA at the NEMO Center (NEuroMuscular Omniservice Clinical Center) in Milan, a neuromuscular patient-centered clinic hosted within Niguarda Hospital, a National Public General Hospital. Our results indicate that the pathway of care described outweighs the burden due to the repeated intrathecal injections. Irrespective of age and severity, the treatment is feasible, accessible, and replicable provided that there is a multidisciplinary team having experience and training in SMA.
AB - Nusinsersen is now available in Italy for all SMA types. We describe the experience with intrathecal treatment with nusinersen in 50 patients with SMA at the NEMO Center (NEuroMuscular Omniservice Clinical Center) in Milan, a neuromuscular patient-centered clinic hosted within Niguarda Hospital, a National Public General Hospital. Our results indicate that the pathway of care described outweighs the burden due to the repeated intrathecal injections. Irrespective of age and severity, the treatment is feasible, accessible, and replicable provided that there is a multidisciplinary team having experience and training in SMA.
KW - SMA
KW - SMA
UR - http://hdl.handle.net/10807/127611
M3 - Article
SN - 1590-1874
SP - 3622
EP - 3629
JO - Neurological Sciences
JF - Neurological Sciences
ER -